Concepedia

Kenneth D. Paull

KD

54

Publications

14.2K

Citations

38

H-Index

1968

Active since

Affiliations

National Cancer Institute(Current)

National Institutes of Health

Frederick National Laboratory for Cancer Research

Fred Hutch Cancer Center

Arizona State University

Kenneth D. Paull is an author at National Cancer Institute specializing in pharmacology, medicine, and drug discovery.

Top concepts

Publications per year

1968–1999

54

Publications

54

Feasibility of a High-Flux Anticancer Drug Screen Using a Diverse Panel of Cultured Human Tumor Cell Lines

Anne Monks, Dominic A. Scudiero, Philip Skehan et al. · JNCI Journal of the National Cancer Institute · 1991 · 3.2K citations

Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines.

Dominic A. Scudiero, Robert H. Shoemaker, Kenneth D. Paull et al. · PubMed · 1988 · 2.4K citations

, , +22

Some practical considerations and applications of the national cancer institute in vitro anticancer drug discovery screen

Michael R. Boyd, Kenneth D. Paull · Drug Development Research · 1995 · 1.5K citations

, , +21

An Information-Intensive Approach to the Molecular Pharmacology of Cancer

John N. Weinstein, Timothy G. Myers, P M O'Connor et al. · Science · 1997 · 1.2K citations

Display and Analysis of Patterns of Differential Activity of Drugs Against Human Tumor Cell Lines: Development of Mean Graph and COMPARE Algorithm

Kenneth D. Paull, Robert H. Shoemaker, Louis Hodes et al. · JNCI Journal of the National Cancer Institute · 1989 · 960 citations

Rows per page

1–5 of 54